Psychiatry and Neurology, Neurology · Coral Springs, FL
NPI
1659494854
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1725 N University Dr, Suite425
Coral Springs, FL, 33071
Phone (954) 539-2030
Groups this clinician bills Medicare through
Medicare paid, 2024
$208K
12,216 services
Medicare patients, 2024
457
Average age 75
Drug cost, 2024
$2.5M
3,684 prescriptions
Company payments, 2025
$13K
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brad M Dajani was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,800 times for 23 patients. In total Brad M Dajani billed 12,216 services in 33 codes, and Medicare paid $208K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,800 | 23 | $4.89 | $48K |
| 99214 Office E&M - Established | Office | 618 | 269 | $100.00 | $62K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 369 | 209 | $12.93 | $4,772 |
| 99204 Office E&M - New | Office | 165 | 165 | $128.97 | $21K |
| 95885 Electrical Nerve Conductivity | Office | 141 | 84 | $48.17 | $6,791 |
| 99232 Hospital E&M - Subsequent | Facility | 91 | 47 | $63.51 | $5,780 |
| 99222 Hospital E&M - Initial | Facility | 85 | 81 | $105.97 | $9,007 |
| 64616 Musculoskeletal | Office | 69 | 22 | $160.70 | $11K |
| 64612 Musculoskeletal | Office | 62 | 20 | $101.28 | $6,280 |
| 95909 Electrical Nerve Conductivity | Office | 45 | 45 | $105.30 | $4,738 |
| 95816 Neurologic | Office | 32 | 31 | $303.58 | $9,715 |
| 95908 Electrical Nerve Conductivity | Office | 26 | 26 | $85.29 | $2,217 |
| 95816 Neurologic | Facility | 19 | 19 | $44.61 | $848 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 17 | 17 | $18.80 | $320 |
| 95910 Electrical Nerve Conductivity | Office | 16 | 16 | $135.38 | $2,166 |
By year: 2022 $133K for 8,463 services; 2023 $137K for 6,913 services; 2024 $208K for 12,216 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brad M Dajani prescribed most often to Medicare patients was Memantine Hcl, with 549 prescriptions and refills. In total Brad M Dajani wrote 3,684 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 549 | 1,324 | 196 | $20K |
| Gabapentin Generic | 206 | 556 | 84 | $5,436 |
| Donepezil Hcl Generic | 173 | 439 | 74 | $1,635 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 166 | 427 | 54 | $3,431 |
| Levetiracetam Generic | 122 | 259 | 36 | $3,442 |
| Primidone Generic | 105 | 252 | 34 | $2,801 |
| Alprazolam Generic | 98 | 104 | 16 | $370 |
| Folic Acid Generic | 90 | 218 | 28 | $497 |
| Rivastigmine Rivastigmine Tartrate | 86 | 166 | 20 | $7,024 |
| Lacosamide Generic | 69 | 84 | 11 | $9,558 |
| Amitriptyline Hcl Generic | 67 | 167 | 21 | $1,618 |
| Duloxetine Hcl Generic | 62 | 162 | 24 | $1,169 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 53 | 106 | 16 | $458 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 49 | 51 | 13 | $1,338 |
| Acetazolamide Generic | 49 | 68 | 19 | $1,068 |
Brand drugs: 483 claims; generic drugs: 3,187 claims; opioid claims: 64.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brad M Dajani $13K ($13K in general payments such as food, travel and fees) from 36 companies. The largest payer was Argenx US, Inc. with $5,485.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 32 | $5,485 |
| UCB, Inc. UCB.BR | 46 | $1,145 |
| Abbvie Inc. ABBV | 29 | $823 |
| EMD Serono, Inc. MRK.DE | 13 | $636 |
| Janssen Biotech, Inc. JNJ | 11 | $512 |
| Biogen, Inc. BIIB | 21 | $433 |
| ACADIA Pharmaceuticals Inc ACAD | 22 | $406 |
| Amneal Pharmaceuticals LLC AMRX | 19 | $338 |
| Teva Pharmaceuticals USA, Inc. TEVA | 17 | $300 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $282 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.